A pervaporation process was implemented into microfluidic chips to purify radiopharmaceuticals for Positron Emission Tomography in continuos-flow. The chip consists of a serpentine microreactor interfaced to a polydimethylsiloxane (PDMS)10 μm thick membrane. Thanks to different volatility of the components present in the radiopharmaceutical matrix, ethanol (EtOH)is readily removed under gentle heating and nitrogen flow conditions. Three classes of chips with different membrane surface areas (S)and internal volumes (V)have been produced and quantified their pervaporative efficiency at different residence times (Rt)and temperatures. Higher S/V chips (̴ 70 mm−1)apperared the most efficient at a very low residence time (Rt ̴ 10 s)allowing reduction of 67% at 80 °C. Chips of intermediate S/V ratios (̴ 30 mm−1)decreased the EtOH amount up to ̴ 90% at longer residence time (Rt ≥ 26 s). The halving of EtOH concentration in a solution of a radiotracer was obtained at 50 °C with Rt of 25 s. After the pervaporation treatment, the EtOH content in the final radiopharmaceutical formulation was demonstrated to be reduced below 10% v/v as required by the European Pharmacopea current edition.
Microfluidic pervaporation of ethanol from radiopharmaceutical formulations
Cellamare S.;Ferorelli S.;Purgatorio R.;Scilimati A.;
2019-01-01
Abstract
A pervaporation process was implemented into microfluidic chips to purify radiopharmaceuticals for Positron Emission Tomography in continuos-flow. The chip consists of a serpentine microreactor interfaced to a polydimethylsiloxane (PDMS)10 μm thick membrane. Thanks to different volatility of the components present in the radiopharmaceutical matrix, ethanol (EtOH)is readily removed under gentle heating and nitrogen flow conditions. Three classes of chips with different membrane surface areas (S)and internal volumes (V)have been produced and quantified their pervaporative efficiency at different residence times (Rt)and temperatures. Higher S/V chips (̴ 70 mm−1)apperared the most efficient at a very low residence time (Rt ̴ 10 s)allowing reduction of 67% at 80 °C. Chips of intermediate S/V ratios (̴ 30 mm−1)decreased the EtOH amount up to ̴ 90% at longer residence time (Rt ≥ 26 s). The halving of EtOH concentration in a solution of a radiotracer was obtained at 50 °C with Rt of 25 s. After the pervaporation treatment, the EtOH content in the final radiopharmaceutical formulation was demonstrated to be reduced below 10% v/v as required by the European Pharmacopea current edition.File | Dimensione | Formato | |
---|---|---|---|
Microfluidic perevaporation.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
1.94 MB
Formato
Adobe PDF
|
1.94 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.